Table 1 Characteristics of patients with either salvage cytotoxic chemotherapy (SC) or best supportive care (BSC)
Characteristic | BSC (n = 48) | SC (n = 38) | P value |
|---|---|---|---|
Age, years [median [IQR]) | 71 (62–76) | 69 (61–75) | 0.71 |
Sex (n [%]) | |||
 Male | 32 (66.6) | 33 (86.8) | 0.043 |
 Female | 16 (33.3) | 5 (13.2) |  |
T Stage (n [%]) | |||
 ≤ pT2 | 15 (31.2) | 12 (31.6) | 0.99 |
 ≥ pT3 | 31 (64.6) | 25 (65.8) |  |
 Unknown | 2 (4.2) | 1 (2.6) |  |
N Stage (n [%]) | |||
 pN0 | 31 (64.6) | 25 (65.8) | 0.91 |
 ≥ pN1 | 17 (35.4) | 13 (34.2) |  |
Grade (n [%]) | |||
 G1/2 | 13 (27.1) | 10 (26.3) | 0.99 |
 G3 | 31 (64.6) | 24 (63.2) |  |
 Unknown | 4 (8.3) | 4 (10.5) |  |
Lymphovascular invasion (n [%]) | |||
 Positive | 29 (60.4) | 25 (65.8) | 0.43 |
 Negative | 17 (35.4) | 10 (26.3) |  |
 Unknown | 2 (4.2) | 3 (7.9) |  |
Carcinoma in situ (n [%]) | |||
 Positive | 6 (12.5) | 4 (10.5) | 0.72 |
 Negative | 40 (83.3) | 34 (89.5) |  |
 Unknown | 2 (4.2) | 0 |  |
Soft-tissue surgical margin (n [%]) | |||
 Positive | 6 (12.5) | 10 (28.9) | 0.10 |
 Negative | 42 (87.5) | 28 (71.1) |  |
Adjuvant chemotherapy (n [%]) | |||
 Yes | 19 (39.6) | 11 (72.7) | 0.30 |
 No | 29 (60.4) | 27 (27.3) |  |
Follow-up, months (median [IQR]) | 17.1 (9.0–39.3) | 27.5 (14.1–40.8) | 0.049 |